Sai Life Sciences commence commercial operations of Unit IV Bidar facility in Karnataka

20 Jun 2025 Evaluate

Sai Life Sciences has commenced commercial operation of the second phase of the production block with 91 kL of capacity at its Unit IV Bidar facility in Karnataka, India, on June 19, 2025. This is the second and final phase of the overall capacity addition of 195 kL which was under construction at Unit IV Bidar Facility as disclosed in the prospectus. 

Accordingly, the combined capacity of Unit IV Bidar Facility will be 640 kL which will be equipped to supply registered starting materials (RSM), intermediates, and active pharmaceutical ingredients (APIs) for both clinical and commercial purposes.

Sai Life Sciences is a pure play fully-integrated, innovator-focused, contract research, development and manufacturing organization.

Sai Life Sciences Share Price

896.45 -3.70 (-0.41%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×